Ion News and Research

RSS

Researchers explore better way to address the root cause of cystic fibrosis

Treatments for cystic fibrosis (CF) have added years to the lives of thousands of Americans. But they can be difficult to administer, and most don't fix the underlying cause. Scientists have now found that a small molecule, when tested in yeast, can substitute for a protein and restore a key cellular function related to those missing in people with CF and similar conditions.

27 Aug 2015

Novel technique may lead to therapies for pain relief in individuals with intractable pain

A team of scientists at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) has developed a novel technique using tiny gold rods to target pain receptors.

24 Aug 2015

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells.

20 Aug 2015

caprotec bioanalytics issued U.S. patent for CCMS proteome analysis technology

caprotec bioanalytics GmbH announced today that the United States Patent Office has issued patent No. US9,034,789 covering its revolutionary Capture Compound Mass Spectrometry (CCMS) technology.

20 Aug 2015

New iPS cell model provides clear drug target for treatment of DMD

Duchenne muscular dystrophy (DMD) is a muscular disease that shows symptoms in early childhood and causes progressive atrophy and eventual death. There is little in terms of treatment, partly because of poor understanding of how DMD develops, although it is known that abnormal expression of the protein dystrophin is at fault.

20 Aug 2015

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Lucideon is pleased to announce the acquisition of a second Dynamic Secondary Ion Mass Spectrometer (DSIMS). The investment doubles the capacity for DSIMS analysis at Lucideon and represents a response to the demand for the service and Lucideon’s commitment to satisfying customer requirements.

From Lucideon 12 Aug 2015

Ion channel blockers prove useful in cancer therapy

Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.

12 Aug 2015

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

Case Western Reserve scientists may have uncovered a molecular mechanism that sets into motion dangerous infection in the feet and hands often occurring with uncontrolled diabetes. It appears that high blood sugar unleashes destructive molecules that interfere with the body's natural infection-control defenses.

7 Aug 2015

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.

4 Aug 2015

Illinois Health and Science acquires IBA Molecular North America

IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today the completion of the previously announced sale of its US operations, IBA Molecular North America, Inc., to Illinois Health and Science (IHS), a non-profit healthcare system based in Decatur, Illinois.

3 Aug 2015

New method helps determine titanium nanoparticles in sunscreen products

Loads of cosmetics like sunscreen lotions contain titanium dioxide. These nanoparticles are contentious. Experts suspect they may have harmful effects on people and the environment.

3 Aug 2015

New technique improves survival time for glioblastoma patients by 50%

The rapid spread of a common and deadly brain tumor has been slowed down significantly in a mouse model by cutting off the way some cancer cells communicate, according to a team of researchers that includes UF Health faculty.

28 Jul 2015

Study: New material that mimics coral could help remove toxic heavy metals from the ocean

A new material that mimics coral could help remove toxic heavy metals like mercury from the ocean, according to a new study published in the Journal of Colloid and Interface Science. The researchers, from Anhui Jianzhu University in China, say their new material could provide inspiration for other approaches to removing pollutants.

25 Jul 2015

Gladstone Institutes announces new business endeavor with Evotec and Dolby Family Ventures

The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.

24 Jul 2015

Common environmental chemicals may act separately or together to increase risk of cancer

Common environmental chemicals assumed to be safe at low doses may act separately or together to disrupt human tissues in ways that eventually lead to cancer, according to a task force of nearly 200 scientists from 28 countries, including one from Oregon State University.

22 Jul 2015

New project aims to revolutionize application of optogenetics in neuroscience

The revolution that optogenetics technology has brought to biology -- neuroscience in particular -- could be transformed all over again if a new project getting underway at Brown University and Central Michigan University is successful.

17 Jul 2015

New non-invasive glucose monitoring device could transform lives of people with diabetes

A new laser sensor that monitors blood glucose levels without penetrating the skin could transform the lives of millions of people living with diabetes.

15 Jul 2015

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications.

7 Jul 2015

New findings can help scientists generate tailor-made proteins optimized for use in optogenetics

Optogenetics techniques, which allow scientists to map and control nerve cells using light stimulation, are being used to study neural circuits in the brain with unprecedented precision. This revolutionary technology relies on light-sensitive proteins such as channelrhodopsins, and researchers at UC Santa Cruz have now determined the molecular mechanism involved in the light-induced activation of one of these proteins.

7 Jul 2015

Transitioning Infrared Imaging into Clinical Use

The CLIRSPEC network is a UK Engineering and Physical Sciences Research Council (EPSRC – EP/L012952/1) funded network in clinical infrared and Raman spectroscopy. Infrared and Raman spectroscopy can identify the hallmarks of disease and distinguish between diseased and non-diseased samples based upon inherent chemistry.

From Daylight Solutions Inc 7 Jul 2015

Ion News and Research

Researchers explore better way to address the root cause of cystic fibrosis

Novel technique may lead to therapies for pain relief in individuals with intractable pain

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

caprotec bioanalytics issued U.S. patent for CCMS proteome analysis technology

New iPS cell model provides clear drug target for treatment of DMD

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Ion channel blockers prove useful in cancer therapy

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

G7 Therapeutics, MorphoSys collaborate on novel antibody therapeutics targeting GPCRs and ion channels

Illinois Health and Science acquires IBA Molecular North America

New method helps determine titanium nanoparticles in sunscreen products

New technique improves survival time for glioblastoma patients by 50%

Study: New material that mimics coral could help remove toxic heavy metals from the ocean

Gladstone Institutes announces new business endeavor with Evotec and Dolby Family Ventures

Common environmental chemicals may act separately or together to increase risk of cancer

New project aims to revolutionize application of optogenetics in neuroscience

New non-invasive glucose monitoring device could transform lives of people with diabetes

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

New findings can help scientists generate tailor-made proteins optimized for use in optogenetics

Transitioning Infrared Imaging into Clinical Use

Enhancing confidence in chemical ionization spectrometry data eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News